Dr Reddys Stock Market Value


USD 54.79  1.50  2.66%   

Dr Reddys' market value is the price at which a share of Dr Reddys stock trades on a public exchange. It measures the collective expectations of Dr Reddys Laboratories investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Dr Reddys Laboratories and determine expected loss or profit from investing in Dr Reddys over a given investment horizon. Additionally, take a look at Dr Reddys Correlation, Dr Reddys Volatility and Dr Reddys Alpha and Beta module to complement your research on Dr Reddys.

Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know Dr Reddys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
9.3 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of Dr Reddys that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine Dr Reddys value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Dr Reddys 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dr Reddys' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dr Reddys.
No Change 0.00  0.0 
In 1 year 11 months and 22 days
If you would invest  0.00  in Dr Reddys on December 15, 2020 and sell it all today you would earn a total of 0.00 from holding Dr Reddys Laboratories or generate 0.0% return on investment in Dr Reddys over 720 days. Dr Reddys is related to or competes with Arbutus Biopharma, ACADIA Pharmaceuticals, AbbVie, Abeona Therapeutics, Acorda Therapeutics, AC Immune, and Agilent Technologies. Reddys Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide More

Dr Reddys Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dr Reddys' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dr Reddys Laboratories upside and downside potential and time the market with a certain degree of confidence.

Dr Reddys Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Reddys' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dr Reddys' standard deviation. In reality, there are many statistical measures that can use Dr Reddys historical prices to predict the future Dr Reddys' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Dr Reddys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Dr Reddys in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
2 Analysts
LowTarget PriceHigh
Estimates (2)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Dr Reddys. Your research has to be compared to or analyzed against Dr Reddys' peers to derive any actionable benefits. When done correctly, Dr Reddys' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Dr Reddys Laboratories.

Dr Reddys Laboratories Backtested Returns

We consider Dr Reddys very steady. Dr Reddys Laboratories retains Efficiency (Sharpe Ratio) of 0.0515, which denotes the company had 0.0515% of return per unit of price deviation over the last 3 months. Our viewpoint regarding predicting the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Dr Reddys, which you can use to evaluate the future volatility of the firm. Please confirm Dr Reddys Laboratories Standard Deviation of 1.48, market risk adjusted performance of 0.1935, and Downside Deviation of 1.62 to check if the risk estimate we provide is consistent with the expected return of 0.0782%.
Dr Reddys has a performance score of 3 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.6131, which means possible diversification benefits within a given portfolio. Let's try to break down what Dr Reddys's beta means in this case. As returns on the market increase, Dr Reddys returns are expected to increase less than the market. However, during the bear market, the loss on holding Dr Reddys will be expected to be smaller as well. Although it is important to respect Dr Reddys Laboratories existing price patterns, it is better to be realistic regarding the information on the equity's price patterns. The way of predicting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By reviewing Dr Reddys Laboratories technical indicators, you can right now evaluate if the expected return of 0.0782% will be sustainable into the future. Dr Reddys Laboratories at this time owns a risk of 1.52%. Please confirm Dr Reddys Laboratories value at risk, and the relationship between the information ratio and kurtosis to decide if Dr Reddys Laboratories will be following its current price history.



Poor predictability

Dr Reddys Laboratories has poor predictability. Overlapping area represents the amount of predictability between Dr Reddys time series from 15th of December 2020 to 10th of December 2021 and 10th of December 2021 to 5th of December 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dr Reddys Laboratories price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Dr Reddys price fluctuation can be explain by its past prices.
Correlation Coefficient0.27
Spearman Rank Test0.1
Residual Average0.0
Price Variance10.88

Dr Reddys Laboratories lagged returns against current returns

Autocorrelation, which is Dr Reddys stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dr Reddys' stock expected returns. We can calculate the autocorrelation of Dr Reddys returns to help us make a trade decision. For example, suppose you find that Dr Reddys stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   

Dr Reddys regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dr Reddys stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dr Reddys stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dr Reddys stock over time.
   Current vs Lagged Prices   

Dr Reddys Lagged Returns

When evaluating Dr Reddys' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dr Reddys stock have on its future price. Dr Reddys autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dr Reddys autocorrelation shows the relationship between Dr Reddys stock current value and its past values and can show if there is a momentum factor associated with investing in Dr Reddys Laboratories.
   Regressed Prices   

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dr Reddys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dr Reddys' short interest history, or implied volatility extrapolated from Dr Reddys options trading.

Currently Active Assets on Macroaxis

Additionally, take a look at Dr Reddys Correlation, Dr Reddys Volatility and Dr Reddys Alpha and Beta module to complement your research on Dr Reddys. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Dr Reddys Stock analysis

When running Dr Reddys Laboratories price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
CEO Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
CEO Directory
Screen CEOs from public companies around the world
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bond Directory
Find actively traded corporate debentures issued by US companies
Dr Reddys technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Dr Reddys technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Dr Reddys trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...